Online citations, reference lists, and bibliographies.
← Back to Search

Acetyl-L-carnitine Fed To Old Rats Partially Restores Mitochondrial Function And Ambulatory Activity.

T. Hagen, R. Ingersoll, C. Wehr, J. Lykkesfeldt, V. Vinarský, J. Bartholomew, M. H. Song, B. Ames
Published 1998 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Mitochondrial function and ambulatory activity were monitored after feeding old rats acetyl-L-carnitine (ALCAR). Young (3-5 mo) and old (22-28 mo) rats were given a 1.5% (wt/vol) solution of ALCAR in their drinking water for 1 mo, were sacrificed, and their liver parenchymal cells were isolated. ALCAR supplementation significantly reverses the age-associated decline of mitochondrial membrane potential, as assessed by rhodamine 123 staining. Cardiolipin, which declines significantly with age, is also restored. ALCAR increases cellular oxygen consumption, which declines with age, to the level of young rats. However, the oxidant production per oxygen consumed, as measured by 2',7'-dichlorofluorescin fluorescence levels, is approximately 30% higher than in untreated old rats. Cellular glutathione and ascorbate levels were nearly 30% and 50% lower, respectively, in cells from ALCAR-supplemented old rats than in untreated old rats, further indicating that ALCAR supplementation might increase oxidative stress. Ambulatory activity in young and old rats was quantified as a general measure of metabolic activity. Ambulatory activity, defined as mean total distance traveled, in old rats is almost 3-fold lower than in young animals. ALCAR supplementation increases ambulatory activity significantly in both young and old rats, with the increase being larger in old rats. Thus, ALCAR supplementation to old rats markedly reverses the age-associated decline in many indices of mitochondrial function and general metabolic activity, but may increase oxidative stress.
This paper references
10.1042/BJ0960777
Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine.
N. Siliprandi (1965)
Biochem. J
N Siliprandi (1965)
10.1063/1.1686375
A new multiparameter separator for microscopic particles and biological cells.
J. Steinkamp (1973)
Rev. Sci. Instrum
J A Steinkamp (1973)
10.1007/978-1-4757-0731-1_13
The effect of age on mitochondrial ultrastructure and enzymes.
P. Wilson (1975)
Adv. Exp. Med. Biol
P D Wilson (1975)
10.1016/S0076-6879(78)52006-5
[4] Isolation and use of liver cells
P. Moldéus (1978)
10.1016/0003-2697(80)90118-9
High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides.
D. Reed (1980)
Anal. Biochem
D J Reed (1982)
10.1016/0531-5565(90)90043-2
Levels of carnitines in brain and other tissues of rats of different ages: Effect of acetyl-L-carnitine administration
F. Maccari (1990)
10.1111/J.1432-1033.1990.TB15331.X
Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine.
M. Gadaleta (1990)
Silicic acid HPLC of cardiolipin, mono- and dilysocardiolipin, and several of their chemical derivatives.
N. Robinson (1990)
Eur. J. Biochem
M N Gadaleta (1990)
Exp. Gerontol
F Maccari (1990)
J. Lipid Res
N C Robinson (1990)
Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins.
S. Narindrasorasak (1992)
10.1021/TX00026A012
Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress.
C. Lebel (1992)
10.1016/0304-4157(92)90035-9
Cardiolipins and biomembrane function.
F. L. Hoch (1992)
10.1016/0047-6374(92)90123-U
Effect of age-related lipid peroxidation on membrane fluidity and phospholipase A2: Modulation by dietary restriction
Byung P. Yu (1992)
10.1016/0005-2736(92)90103-S
The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria.
G. Paradies (1992)
Mech. Ageing Dev
B P Yu (1992)
Chem. Res. Toxicol
C P Lebel (1992)
Biochim. Biophys. Acta
F L Hoch (1992)
Biochim. Biophys. Acta
G Paradies (1992)
Alzheimer's disease : amyloid precursor proteins, signal transduction, and neuronal transplantation
R. Nitsch (1993)
10.1016/0014-5793(94)00763-2
Effect of aging and acetyl‐l‐carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria
Giuseppe Paradies (1994)
10.1073/PNAS.91.23.10771
Oxidative damage and mitochondrial decay in aging.
M. Shigenaga (1994)
10.1016/0006-8993(94)91480-X
Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-l-carnitine administration
C. Bertoni-Freddari (1994)
Brain Res
C Bertoni-Freddari (1994)
Neurochem. Res
M Castornia (1994)
Proc. Natl. Acad. Sci. USA 91
M K Shigenaga (1994)
10.1006/ABIO.1995.1421
Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection--are they reliable biomarkers of oxidative stress?
J. Lykkesfeldt (1995)
10.1016/0047-6374(95)01636-8
Carnitine-acylcarnitine translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-L-carnitine
G. Paradies (1995)
10.1016/0165-0270(95)00018-P
Monitoring intracellular nitric oxide formation by dichlorofluorescin in neuronal cells
P. Gunasekar (1995)
Anal. Biochem
J Lykkesfeldt (1995)
J. Neurosci. Methods
P G Gunasekar (1995)
Mech. Ageing Dev
G Paradies (1995)
10.1126/SCIENCE.273.5271.59
Oxidative Stress, Caloric Restriction, and Aging
R. Sohal (1996)
10.1016/S1056-8719(97)00066-X
Determination of nitric oxide generation in mammalian neurons using dichlorofluorescin diacetate and flow cytometry.
C. Gabriel (1997)
10.1073/PNAS.94.7.3064
Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase.
T. Hagen (1997)
10.1074/JBC.272.33.20313
Protein Oxidation in Aging, Disease, and Oxidative Stress*
B. S. Berlett (1997)
10.1016/S0168-8278(97)80358-3
Age-dependent modifications in rat hepatocyte antioxidant defense systems.
N. Sanz (1997)
10.3109/10715769709065763
Oxidation of 2',7'-dichlorofluorescin by peroxynitrite.
N. Kooy (1997)
10.1016/S0009-8981(97)00106-X
Lipid peroxidation and antioxidant status in experimental animals: effects of aging and hypercholesterolemic diet.
D. Erdinçler (1997)
J. Hepatol
N Sanz (1997)
J. Pharmacol. Toxicol. Methods
C Gabriel (1997)
J. Biol. Chem
B S Berlett (1997)
Clin. Chim. Acta
D S Erdincler (1997)
Free Radical Res
N W Kooy (1997)
Proc. Natl. Acad. Sci. USA 94
T M Hagen (1997)
Towards Prolongation of the Healthy Life Span: Practical Approaches to Intervention. Proceedings of a conference. Adelaide, Australia, August 15-18, 1997.
D. Harman (1998)
10.1152/PHYSREV.1998.78.2.547
The free radical theory of aging matures.
K. Beckman (1998)
Toward Prolongation of the Healthy Life Span: Practical Approaches to Intervention
T M Hagen (1998)
Neurochem. Res
R F Villa (1998)
Practical Approaches to Intervention, eds
T. M. Hagen (1998)
Physiol. Rev
K B Beckman (1998)
10.1136/bmj.321.7272.1341/a
Age
(2000)
10.1016/S0014-5793(00)01734-8
FEBS Lett
M. Saraste (2000)



This paper is referenced by
10.1016/j.ymgme.2021.01.011
Therapies for Alzheimer's disease: a metabolic perspective.
R. Domingues (2021)
10.1007/s10103-021-03304-2
Combination photobiomodulation/N-acetyl-L-cysteine treatment appears to mitigate hair cell loss associated with noise-induced hearing loss in rats
C. Rhee (2021)
10.3390/biom11040612
Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
F. Church (2021)
10.3389/fnmol.2021.720220
Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives
Dominika Przewodowska (2021)
10.1002/advs.202101222
Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
O. Altay (2021)
10.1097/TGR.0000000000000278
Integrative Medicine and Health Therapy for Parkinson Disease
M. Hall (2020)
10.3390/ijms21217984
Treating Senescence like Cancer: Novel Perspectives in Senotherapy of Chronic Diseases
A. Mongelli (2020)
10.20996/1819-6446-2020-02-11
Levocarnitine for the Treatment of Polymorbid Patients
A. Pereverzev (2020)
10.1101/2020.10.02.20202614
Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19
O. Altay (2020)
10.1186/s12950-020-00253-5
Offspring sex affects the susceptibility to maternal smoking-induced lung inflammation and the effect of maternal antioxidant supplementation in mice
Baoming Wang (2020)
10.1089/ars.2019.7763
Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.
Yunhua Peng (2020)
10.1038/s41598-020-60457-w
Uncovering pathophysiological changes in frontotemporal dementia using serum lipids
Katherine Phan (2020)
10.1042/CS20190559
Targeting mitochondrial fitness as a strategy for healthy vascular aging.
M. Rossman (2020)
The Role of mtDNA Mutation and Mitochondrial Dysfunction on the Aging Process
Starr Pericles (2019)
10.1016/J.MEHY.2019.04.015
Tetra-linoleoyl cardiolipin depletion plays a major role in the pathogenesis of sarcopenia.
R. Semba (2019)
10.26442/00403660.2019.01.000040
Significance of L-carnitine in internal medicine.
Z. Sizova (2019)
10.1016/j.jpsychires.2019.08.003
Treatment for Gulf War Illness (GWI) with KPAX002 (methylphenidate hydrochloride + GWI nutrient formula) in subjects meeting the Kansas case definition: A prospective, open-label trial (revision 2).
M. Holodniy (2019)
10.1016/j.neulet.2019.05.009
Ketamine-induced attenuation of reactive oxygen species in zebrafish is prevented by acetyl l-carnitine in vivo
B. Robinson (2019)
KPAX 002 as a treatment for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome ( ME / CFS ) : a prospective , randomized trial
J. Montoya (2018)
10.1016/B978-0-12-811908-2.00014-3
Anti-Oxidant Treatment
S. Tsalamandris (2018)
10.1016/j.trsl.2018.07.015
Mitochondrial regulation of diabetic vascular disease: an emerging opportunity.
M. Widlansky (2018)
10.4274/tjps.70299
Synthesis and Antioxidant Properties of New Oxazole-5(4H)-one Derivatives
C. Kuş (2017)
10.1016/j.exger.2017.08.017
Dietary supplementation with acetyl-l-carnitine counteracts age-related alterations of mitochondrial biogenesis, dynamics and antioxidant defenses in brain of old rats
L. Nicassio (2017)
10.3945/an.117.015610
Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps.
M. Fenech (2017)
10.1097/SCS.0000000000003353
The Effect of Carnitine on Peripheral Nerve Regeneration
Kemal Karaca (2017)
10.13005/bpj/1143
Acetyl-L-Carnitine Restores Abnormal Lipid Metabolism Induced by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin in Mice
S. Magesh (2017)
Nutraceutical intervention in ageing brain
S. Domenico (2017)
10.21522/TIJBMS.2016.02.01.ART005
Neuroprotective Epigenetic and DNA Damage Repairing Molecular Mechanisms of L-Carnitine and its Congeners against Aging and Age-Related Neurodegenerative Diseases
K. Ponnusamy (2017)
10.3389/fnmol.2017.00033
Maternal L-Carnitine Supplementation Improves Brain Health in Offspring from Cigarette Smoke Exposed Mothers
Y. L. Chan (2017)
10.1111/acel.12608
Identification of tissue‐specific transcriptional markers of caloric restriction in the mouse and their use to evaluate caloric restriction mimetics
J. Barger (2017)
3. ROLE OF THE CARNITINES IN THE BRAIN 3.1. Modulation in neurotransmission
G. Traina (2016)
10.1016/j.neurobiolaging.2015.09.015
Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine
S. Snigdha (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar